Time above the MIC of Piperacillin-Tazobactam as a Predictor of Outcome in Pseudomonas aeruginosa Bacteremia

Elias Tannous, Shelly Lipman, Antonella Tonna, Emma E. Hector, Ziad Hussein, Michal Stein, Sharon Reisfeld

Antimicrobial Agents and Chemotherapy · 2020 · 30 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

Pseudomonas aeruginosa bacteremia is an infection associated with a high mortality rate. Piperacillin-tazobactam is a β-lactam–β-lactamase inhibitor combination that is frequently used for the management of Pseudomonas aeruginosa infections. The pharmacokinetic-pharmacodynamic index associated with in vitro maximal bacterial killing for piperacillin-tazobactam is the percentage of the time between doses at which the free fraction concentration remains above the MIC (% fT >MIC ).

References

24